These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17889261)

  • 1. May some cases of intermittent hydrarthrosis represent an atypical form of calcium pyrophosphate dihydrate crystal deposition disease? Usefulness of mutational analysis of the MEFV gene.
    Queiro R; Cañete J; Arostegui JI; Yague J
    Semin Arthritis Rheum; 2008 Feb; 37(4):269-70. PubMed ID: 17889261
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of intermittent hydrarthrosis with MEFV gene mutations.
    Cañete JD; Aróstegui JI; Queiró R; Sanmartí R; Ballina J; Bosch X; Yagüe J
    Arthritis Rheum; 2006 Jul; 54(7):2334-5. PubMed ID: 16802374
    [No Abstract]   [Full Text] [Related]  

  • 3. The evaluation of gene polymorphisms associated with autoinflammatory syndrome in patients with palindromic rheumatism complicated by intermittent hydrarthrosis.
    Tani Y; Kishi T; Miyamae T; Kawamoto M; Kawaguchi Y; Taniguchi A; Yamanaka H
    Clin Rheumatol; 2020 Mar; 39(3):841-845. PubMed ID: 31897954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chondrocalcinosis or calcium pyrophosphate dihydrate (CPPD) crystal deposition disease. Report of a familial case].
    Fantechi V; Lazzeri S; Baldoni D; Maranghi P
    Radiol Med; 1993 Jun; 85(6):850-3. PubMed ID: 8337446
    [No Abstract]   [Full Text] [Related]  

  • 5. An unexpectedly high frequency of MEFV mutations in patients with anti-citrullinated protein antibody-negative palindromic rheumatism.
    Cañete JD; Arostegui JI; Queiró R; Gratacós J; Hernández MV; Larrosa M; Alperí M; Moll C; Rius J; Sanmartí R; Yagüe J
    Arthritis Rheum; 2007 Aug; 56(8):2784-8. PubMed ID: 17665427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Familial articular chondrocalcinosis: study of an Alsatian family].
    Netter P; Loeuille D; Jouzeau JY; Gillet P; Peterschmitt J; Pourel J; Gaucher A
    Bull Acad Natl Med; 2001; 185(2):417-24; discussion 424-6. PubMed ID: 11474594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familiar association of Gitelman's syndrome and calcium pyrophosphate dihydrate crystal deposition disease--a case report.
    Volpe A; Caramaschi P; Thalheimer U; Fava C; Ravagnani V; Bambara LM; Biasi D
    Rheumatology (Oxford); 2007 Sep; 46(9):1506-8. PubMed ID: 17666441
    [No Abstract]   [Full Text] [Related]  

  • 8. [Familiar chondrocalcinosis: a story for two brothers].
    Ambrósio C; Garcia J; Salvador M; Malcata A
    Acta Reumatol Port; 2008; 33(3):352-6. PubMed ID: 18846014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of chondrocalcinosis.
    Zaka R; Williams CJ
    Osteoarthritis Cartilage; 2005 Sep; 13(9):745-50. PubMed ID: 15951203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial chondrocalcinosis in the Spanish population.
    Fernandez Dapica MP; Gómez-Reino JJ
    J Rheumatol; 1986 Jun; 13(3):631-3. PubMed ID: 3735284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium pyrophosphate dihydrate-crystal induced arthropathy].
    Schneider Internist-Rheumatologe Chefarzt Der Abteilung Für Rheumatologie P; Schneider I
    Z Rheumatol; 2004 Feb; 63(1):10-21. PubMed ID: 14991274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute sacroiliitis as a manifestation of calcium pyrophosphate dihydrate crystal deposition disease. A report of two cases.
    François S; Guaydier-Souquieres G; Marcelli C
    Rev Rhum Engl Ed; 1997; 64(7-9):508-12. PubMed ID: 9338935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis of MEFV gene pyrin domain in patients with Behçet's disease.
    Dursun A; Durakbasi-Dursun HG; Zamani AG; Gulbahar ZG; Dursun R; Yakicier C
    Mediators Inflamm; 2006; 2006(3):41783. PubMed ID: 16951489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of primary articular chondrocalcinosis.
    Zitnan D; Sitaj S
    Czech Med; 1979; 2(3):89-103. PubMed ID: 535502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiple tendon ruptures in a case of calcium pyrophosphate crystal deposit disease (chondrocalcinosis)].
    van Linthoudt D; Gabay C; Ott H
    Schweiz Med Wochenschr; 1989 Aug; 119(34):1164-5. PubMed ID: 2814411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anakinra for a refractory case of intermittent hydrarthrosis with a TRAPS-related gene mutation.
    Andrés M; Pascual E
    Ann Rheum Dis; 2013 Jan; 72(1):155. PubMed ID: 22887853
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutations in the amino terminus of ANKH in two US families with calcium pyrophosphate dihydrate crystal deposition disease.
    Williams CJ; Pendleton A; Bonavita G; Reginato AJ; Hughes AE; Peariso S; Doherty M; McCarty DJ; Ryan LM
    Arthritis Rheum; 2003 Sep; 48(9):2627-31. PubMed ID: 13130483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium pyrophosphate dihydrate crystal deposition disease.
    Bencardino JT; Hassankhani A
    Semin Musculoskelet Radiol; 2003 Sep; 7(3):175-85. PubMed ID: 14593559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chondrocalcinosis is a feature of Gitelman's variant of Bartter's syndrome. A new look at the hypomagnesemia associated with calcium pyrophosphate dihydrate crystal deposition disease.
    Punzi L; Calò L; Schiavon F; Pianon M; Rosada M; Todesco S
    Rev Rhum Engl Ed; 1998 Oct; 65(10):571-4. PubMed ID: 9809361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium pyrophosphate dihydrate deposition disease without chondrocalcinosis.
    Utsinger PD; Zvaifler NJ; Resnick D
    J Rheumatol; 1975 Sep; 2(3):258-64. PubMed ID: 171407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.